Skip to content
  • News
  • Anal Cancer
  • Bladder Cancer
  • Bone Cancer
  • Brain Cancer
  • Breast Cancer
  • Cancer of Unknown Primary
  • Cervical Cancer
  • Colon Cancer
  • Esophageal Cancer
  • Gastric Cancer
  • GIST
  • Head & Neck Cancer
  • Hodgkins Lymphoma
  • Leukemia
    • Acute Leukemia
    • Chronic Lymphocytic Leukemia
    • Chronic Myeloid Leukemia
  • Liver Cancer
  • Lung Cancer
  • Melanoma
  • Mesothelioma
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • MPN-PV-ET-MF
  • Neuroblastoma
  • Neuroendocrine Tumors
  • Non Hodgkins Lymphoma
  • Ovarian Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • Renal Cancer
  • Rectal Cancer
  • Sarcoma
  • Skin Care
  • Skin Cancer
  • Testicular Cancer
  • Thyroid Cancer
  • Triple Negative Breast Cancer
  • Uterine Cancer
  • About Us
  • Advertising
  • News
  • Newly Diagnosed
  • Treatment & Care
  • Survivorship
  • Join the Community
  • Newsletter

Treatment & Care

  • Vorinostat Cuts Risk of Graft-Versus-Host Disease in Half
    June 1, 2018

    Vorinostat Cuts Risk of Graft-Versus-Host Disease in Half

    Dr. C H Weaver MD
  • Frequently Asked Questions about Inlyta® (axitinib)
    June 1, 2018

    Frequently Asked Questions about Inlyta® (axitinib)

    Dr. C H Weaver MD
  • Frequently Asked Questions About Neumega (oprelvekin)
    June 1, 2018

    Frequently Asked Questions About Neumega (oprelvekin)

    Dr. C H Weaver MD
  • Frequently Asked Questions About Somatuline® Depot (Lanreotide)
    June 1, 2018

    Frequently Asked Questions About Somatuline® Depot (Lanreotide)

    Dr. C H Weaver MD
  • Frequently Asked Questions About Ethyol (amifostine)
    June 1, 2018

    Frequently Asked Questions About Ethyol (amifostine)

    Dr. C H Weaver MD
  • Frequently Asked Questions about Cyramza® (ramucirumab)
    June 1, 2018

    Frequently Asked Questions about Cyramza® (ramucirumab)

    Dr. C H Weaver MD
  • Frequently Asked Questions About Lupron®
    June 1, 2018

    Frequently Asked Questions About Lupron®

    Dr. C H Weaver MD
  • Frequently Asked Questions About DTIC-Dome® (Dacarbazine)
    June 1, 2018

    Frequently Asked Questions About DTIC-Dome® (Dacarbazine)

    Dr. C H Weaver MD
  • BEVYXXA® – Frequently Asked Questions About BEVYXXA® (betrixaban)
    June 1, 2018

    BEVYXXA® – Frequently Asked Questions About BEVYXXA® (betrixaban)

    Dr. C H Weaver MD
  • Frequently Asked Questions About Jevtana® (cabazitaxel)
    June 1, 2018

    Frequently Asked Questions About Jevtana® (cabazitaxel)

    Dr. C H Weaver MD
  • Frequently Asked Questions About Vumon® (Teniposide)
    June 1, 2018

    Frequently Asked Questions About Vumon® (Teniposide)

    Dr. C H Weaver MD
  • Frequently Asked Questions About Ellence® (Epirubicin)
    June 1, 2018

    Frequently Asked Questions About Ellence® (Epirubicin)

    Dr. C H Weaver MD
Previous Page
1 … 31 32 33 34 35 … 73
Next Page
  • Sitemap
  • About Us
  • Advertising
  • Privacy Policy
Loading Comments...